Short answer
Lifevantage Corp (LFVN) filed its Q3 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $37M (down 22.0% year over year) with net income of −$196,000.
Q3 2026 key financials · XBRL
- Revenue
- $37M
- −22.0% YoY
- Net income
- −$196,000
- −109.1% YoY
- Operating margin
- -0.4%
- Gross margin
- 75.4%
- EPS (diluted)
- −$0.02
- −111.8% YoY
Source: XBRL data from the Lifevantage Corp (LFVN) Q3 2026 10-Q on SEC EDGAR. USD.
Lifevantage Corp Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $37.1M, down from $47.6M YoY, driven by fewer active accounts and MindBody GLP-1 declines
- Gross margin 75.4% vs 79.5%, pressured by $1.3M inventory obsolescence costs
- MindBody GLP-1 worst-performing line, sales down $4.4M; LoveBiome products partially offset declines
- Cash $13.7M, down from $14.9M; operating cash flow $0.5M vs $(2.3)M YoY
- Active accounts down 19.0% to 98,000; management expects cash and operations to fund needs for at least 12 months
Risk Factors
- No material risk-factor changes from the June 30, 2026 Form 10-K
- Carried-forward business risks remain those disclosed in the August 27, 2026 annual filing
- Share-repurchase liquidity commitment: $60.0 million authorization through December 31, 2027
- Regulatory compliance remains governed by applicable securities laws and Rule 10b5-1 requirements
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Lifevantage Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.